alanine and naloxone

alanine has been researched along with naloxone in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (55.56)	18.7374
1990's	1 (11.11)	18.2507
2000's	1 (11.11)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (22.22)	2.80

Authors

Authors	Studies
Ho, IK; Loh, HH; Way, EL	1
Larson, AA	1
Contreras, E; Tamayo, L	1
Alberti, KG; Barnett, AH; Eff, C; Leslie, RD; Pyke, DA; Spiliopoulos, AJ; Stubbs, WA	1
Holm, AC; Ogren, SO	1
George, SR; O'Dowd, BF; Pak, Y	1
Deng, HB; Guang, W; Wang, JB	1
Bruno, V; Farcy, N; Karnik, V; Zamorano, C	1
Atwal, H; Ayoub, SM; Collins, SA; Di Marzo, V; Farag, M; Iannotti, FA; Leri, F; Lichtman, AH; Limebeer, CL; Mechoulam, R; Parker, LA; Piscitelli, F; Rock, EM; Smoum, R	1

Reviews

1 review(s) available for alanine and naloxone

Article	Year
Current Status of Pain Management in Parkinson's Disease. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2020, Volume: 47, Issue:3 Topics: Acetylcholine Release Inhibitors; Alanine; Analgesics; Antiparkinson Agents; Apomorphine; Benzylamines; Botulinum Toxins, Type A; Deep Brain Stimulation; Dopamine Agonists; Drug Combinations; Duloxetine Hydrochloride; Humans; Levodopa; Naloxone; Oxycodone; Pain; Pain Management; Pain Measurement; Pain Threshold; Parkinson Disease; Tetrahydronaphthalenes; Thiophenes	2020

Article

Year

Current Status of Pain Management in Parkinson's Disease.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2020, Volume: 47, Issue:3

Topics: Acetylcholine Release Inhibitors; Alanine; Analgesics; Antiparkinson Agents; Apomorphine; Benzylamines; Botulinum Toxins, Type A; Deep Brain Stimulation; Dopamine Agonists; Drug Combinations; Duloxetine Hydrochloride; Humans; Levodopa; Naloxone; Oxycodone; Pain; Pain Management; Pain Measurement; Pain Threshold; Parkinson Disease; Tetrahydronaphthalenes; Thiophenes

2020

Trials

1 trial(s) available for alanine and naloxone

Article	Year
Opiate receptors and the metabolic response to intravenous glucose. Diabete & metabolisme, 1982, Volume: 8, Issue:3 Topics: Alanine; Blood Glucose; Chlorpropamide; Ethanol; Glucagon; Glucose; Humans; Insulin; Kinetics; Lactates; Lactic Acid; Naloxone; Pyruvates; Pyruvic Acid; Receptors, Opioid	1982

Other Studies

7 other study(ies) available for alanine and naloxone

Article	Year
Pharmacological manipulation of gamma-aminobutyric acid (GABA) in morphine analgesia, tolerance and physical dependence. Life sciences, 1976, May-15, Volume: 18, Issue:10 Topics: Alanine; Aminobutyrates; Aminooxyacetic Acid; Analgesia; Animals; Bicuculline; Biological Transport; Drug Interactions; Drug Tolerance; gamma-Aminobutyric Acid; Humans; Male; Mice; Mice, Inbred ICR; Morphine; Naloxone; Receptors, Drug; Substance Withdrawal Syndrome; Substance-Related Disorders	1976
Intrathecal GABA, glycine, taurine or beta-alanine elicits dyskinetic movements in mice. Pharmacology, biochemistry, and behavior, 1989, Volume: 32, Issue:2 Topics: Alanine; Animals; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Glycine; Injections, Intraperitoneal; Injections, Spinal; Male; Mice; Morphine; Movement Disorders; Naloxone; Strychnine; Taurine; Time Factors	1989
Effects of glycine, beta-alanine and diazepam upon morphine-tolerant-dependent mice. The Journal of pharmacy and pharmacology, 1980, Volume: 32, Issue:5 Topics: Alanine; Analgesia; Animals; beta-Alanine; Diazepam; Drug Interactions; Drug Tolerance; Female; Glycine; Humans; Mice; Morphine; Morphine Dependence; Naloxone; Substance Withdrawal Syndrome	1980
Test-specific effects of the 5-HT reuptake inhibitors alaproclate and zimelidine on pain sensitivity and morphine analgesia. Journal of neural transmission, 1980, Volume: 47, Issue:4 Topics: Alanine; Analgesia; Animals; Behavior, Animal; Brompheniramine; Desipramine; Dose-Response Relationship, Drug; Male; Morphine; Naloxone; p-Chloroamphetamine; Pain; Pyridines; Rats; Serotonin; Zimeldine	1980
Agonist-induced desensitization of the mu opioid receptor is determined by threonine 394 preceded by acidic amino acids in the COOH-terminal tail. The Journal of biological chemistry, 1997, Oct-03, Volume: 272, Issue:40 Topics: Alanine; Amino Acid Sequence; Animals; Binding, Competitive; CHO Cells; Cricetinae; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Kinetics; Molecular Sequence Data; Mutagenesis, Site-Directed; Naloxone; Point Mutation; Rats; Receptors, Opioid, mu; Recombinant Proteins; Serine; Threonine; Transfection	1997
Selected cysteine residues in transmembrane domains of mu-opioid receptor are critical for effects of sulfhydryl reagents. The Journal of pharmacology and experimental therapeutics, 2000, Volume: 293, Issue:1 Topics: Alanine; Amino Acid Sequence; Amino Acid Substitution; Animals; CHO Cells; COS Cells; Cricetinae; Cysteine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Ethyl Methanesulfonate; Humans; Ligands; Membranes; Mesylates; Molecular Sequence Data; Mutagenesis, Site-Directed; Naloxone; Narcotic Antagonists; Radioligand Assay; Receptors, Opioid, mu; Sulfhydryl Reagents	2000
Oleoyl alanine (HU595): a stable monomethylated oleoyl glycine interferes with acute naloxone precipitated morphine withdrawal in male rats. Psychopharmacology, 2020, Volume: 237, Issue:9 Topics: Alanine; Analgesics, Opioid; Animals; Glycine; Male; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Oleic Acids; Rats; Rats, Sprague-Dawley; Reward; Substance Withdrawal Syndrome	2020